Holen Sie sich die Stockscreener-App
3.33
3.76%
-0.13
Handel nachbörslich:
3.39
0.06
+1.80%
Schlusskurs vom Vortag:
$3.46
Offen:
$3.47
24-Stunden-Volumen:
155.55K
Relative Volume:
0.41
Marktkapitalisierung:
$264.26M
Einnahmen:
$351.37M
Nettoeinkommen (Verlust:
$-174.01M
KGV:
-1.6087
EPS:
-2.07
Netto-Cashflow:
$-126.94M
1W Leistung:
-4.03%
1M Leistung:
-5.67%
6M Leistung:
+14.83%
1J Leistung:
-8.26%
1-Tages-Spanne:
$3.305
$3.47
1-Wochen-Bereich:
$3.305
$3.525
52-Wochen-Spanne:
$2.455
$4.145
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
Firmenname
Atea Pharmaceuticals Inc
Sektor
Branche
Telefon
857-204-8109
Adresse
225 FRANKLIN STREET, BOSTON
Vergleichen Sie AVIR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVIR
Atea Pharmaceuticals Inc
|
3.33 | 269.82M | 351.37M | -174.01M | -126.94M | -2.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-13 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2023-08-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-18 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-20 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-10-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-25 | Eingeleitet | Evercore ISI | Outperform |
| 2020-11-24 | Eingeleitet | JP Morgan | Overweight |
| 2020-11-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Atea Pharmaceuticals Inc Aktie (AVIR) Neueste Nachrichten
Is it too late to sell Atea Pharmaceuticals Inc.2025 Retail Activity & High Return Stock Watch Alerts - Newser
Short interest data insights for Atea Pharmaceuticals Inc.2025 Trading Recap & Free Daily Entry Point Trade Alerts - Newser
Will Atea Pharmaceuticals Inc. benefit from macro trendsEarnings Beat & Weekly Watchlist of Top Performers - Newser
Does Atea Pharmaceuticals Inc. qualify in momentum factor screening2025 Earnings Impact & Community Verified Swing Trade Signals - Newser
Analyzing Atea Pharmaceuticals Inc. with risk reward ratio charts2025 Risk Factors & Weekly Hot Stock Watchlists - Newser
Should you hold or exit Atea Pharmaceuticals Inc. nowJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - Newser
Russell Investments Group Ltd. Purchases 54,398 Shares of Atea Pharmaceuticals, Inc. $AVIR - Defense World
Evaluating Atea Pharmaceuticals Inc. with trendline analysis2025 Fundamental Recap & Daily Technical Forecast Reports - Newser
What technical models suggest about Atea Pharmaceuticals Inc.’s comeback - Newser
How to monitor Atea Pharmaceuticals Inc. with trend dashboardsJuly 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - Newser
What to do if you’re stuck in Atea Pharmaceuticals Inc.Weekly Trade Summary & Technical Pattern Based Signals - Newser
what’s next for atea pharmaceuticals inc. stock price2025 Price Targets & Precise Trade Entry Recommendations - Newser
Is Atea Pharmaceuticals Inc. likely to announce a buybackGlobal Markets & Stepwise Trade Signal Implementation - khodrobank.com
Using data tools to time your Atea Pharmaceuticals Inc. exitJuly 2025 Outlook & Technical Pattern Alert System - Newser
Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewswire
Will Atea Pharmaceuticals Inc. outperform tech stocksJuly 2025 Technicals & Entry Point Confirmation Alerts - khodrobank.com
What momentum shifts mean for Atea Pharmaceuticals Inc.Portfolio Return Report & Consistent Profit Trade Alerts - Newser
Building trade automation scripts for Atea Pharmaceuticals Inc.Quarterly Market Review & Verified Technical Trade Signals - Newser
What dividend growth rate does Atea Pharmaceuticals Inc. offerMarket Volume Summary & Low Risk High Win Rate Stock Picks - khodrobank.com
Antiviral Drug Developer Atea Pharmaceuticals to Present Latest Pipeline Updates at Morgan Stanley Conference - Stock Titan
How sensitive is Atea Pharmaceuticals Inc. to inflation2025 Buyback Activity & Smart Swing Trading Techniques - khodrobank.com
What’s next for Atea Pharmaceuticals Inc. stock priceBuy Signal & Fast Gain Swing Alerts - Newser
What are Atea Pharmaceuticals Inc.’s earnings expectationsDollar Strength & Weekly Market Pulse Updates - khodrobank.com
Charles Schwab Investment Management Inc. Reduces Position in Atea Pharmaceuticals, Inc. $AVIR - Defense World
Deutsche Bank AG Buys Shares of 60,263 Atea Pharmaceuticals, Inc. $AVIR - Defense World
Signal strength of Atea Pharmaceuticals Inc. stock in tech scannersEarnings Growth Report & Risk Adjusted Buy/Sell Alerts - Newser
Volatility clustering patterns for Atea Pharmaceuticals Inc.2025 Historical Comparison & Real-Time Stock Movement Alerts - Newser
How sensitive is Atea Pharmaceuticals Inc. to inflation getLinesFromResByArray error: size == 0 - sisain.net
Intraday pattern recognizer results for Atea Pharmaceuticals Inc.Quarterly Portfolio Report & Expert Approved Momentum Trade Ideas - Newser
What makes Atea Pharmaceuticals Inc. stock price move sharply getLinesFromResByArray error: size == 0 - sisain.net
Will Atea Pharmaceuticals Inc. price bounce be sustainable2025 Key Highlights & Consistent Return Investment Signals - Newser
What earnings revisions data tells us about Atea Pharmaceuticals Inc.Weekly Investment Report & Weekly Watchlist of Top Performers - Newser
What Fibonacci levels say about Atea Pharmaceuticals Inc. reboundJuly 2025 Snapshot & Consistent Income Trade Recommendations - Newser
Atea Pharmaceuticals Inc. Nearing Breakout Level After BounceJuly 2025 PostEarnings & Reliable Breakout Stock Forecasts - beatles.ru
Atea Pharmaceuticals Inc. stock daily chart insights2025 Retail Activity & Long-Term Safe Investment Plans - Newser
Finanzdaten der Atea Pharmaceuticals Inc-Aktie (AVIR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Atea Pharmaceuticals Inc-Aktie (AVIR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
506,497 |
| Duncan Barbara Gayle | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Polsky Bruce | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
95,206 |
| Adams Jerome M. | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Lucidi Bruno | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
112,750 |
| BERGER FRANKLIN M | Director |
Dec 10 '24 |
Sale |
2.85 |
359,606 |
1,023,475 |
451,897 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):